| News | Events |
| Publications | Companies |
| Clinical Trials |
Monthly Archives: November 2006
-
Contine Reading & Discuss→
-
Copenhagen, 28 November 2006 Santaris Pharma, the Danish biopharmaceutical company developing RNA Targeted Medicines, announced that it has won Ernst & Young’s "Entrepreneur of the Year 2006" award in Denmark for the biotech category. Around 750 delegates attended the annual Ernst & Young ceremony in Copenhagen in late November. read... Contine Reading & Discuss→Santaris Pharma awarded Ernst & Young Entrepreneur of the Year 2006
0 Replies
-
Contine Reading & Discuss→Grant of Options
0 Replies
-
Contine Reading & Discuss→Share Issue
0 Replies
-
Contine Reading & Discuss→Placing of Shares
0 Replies
-
Contine Reading & Discuss→Holdings in Company
0 Replies
-
Contine Reading & Discuss→SR Pharma plc Announces the Successful Completion of Toxicology Studies for it’s Systematically Delivered RNAi Product Candidate Atu027
0 Replies
-
Contine Reading & Discuss→Placing of Shares
0 Replies
-
Copenhagen, November 6, 2006 Santaris Pharma, the Danish biopharmaceutical company developing RNA Antagonist drugs for the treatment of cancer and metabolic disorders, announced today that Keith McCullagh, President and Chief Executive Officer, will be presenting an overview of the company and progress in its product pipeline at the Rodman &... Contine Reading & Discuss→Santaris Pharma to present at Rodman & Renshaw 8th Annual Healthcare Conference – November 6th 2006
0 Replies

